OPK - OPKO Health, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Miami,
United States
Type: Equity
OPK price evolution
OPK
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $95.88 | $138.62 | $108.11 | $110.83 |
| Short term investments | ||||
| Net receivables | $123.38 | $117.45 | $210.98 | $121.49 |
| Inventory | $65.7 | $68.96 | $73.75 | $75.41 |
| Total current assets | $309.48 | $357.24 | $433.79 | $406.42 |
| Long term investments | $16.08 | $19.38 | $27.78 | $41.23 |
| Property, plant & equipment | $143.52 | $122.86 | $113.81 | $117.69 |
| Goodwill & intangible assets | $1338.54 | $1352.87 | $1379.57 | $1401 |
| Total noncurrent assets | $1702.22 | $1699.44 | $1725.11 | $1763.25 |
| Total investments | $16.08 | $19.38 | $27.78 | $41.23 |
| Total assets | $2011.7 | $2056.68 | $2158.9 | $2169.67 |
| Current liabilities | ||||
| Accounts payable | $69.68 | $66.8 | $87.88 | $80.5 |
| Deferred revenue | ||||
| Short long term debt | $40.29 | $41.38 | $39.97 | $35.86 |
| Total current liabilities | $200.05 | $200.55 | $226.45 | $222.42 |
| Long term debt | $268.46 | $247.93 | $237.21 | $237.79 |
| Total noncurrent liabilities | $422.43 | $411.56 | $397.1 | $395.44 |
| Total debt | $308.75 | $289.32 | $277.18 | $273.65 |
| Total liabilities | $622.48 | $612.11 | $623.55 | $617.86 |
| Shareholders' equity | ||||
| Retained earnings | -$2011.79 | -$1945.3 | -$1860.83 | -$1841.19 |
| Other shareholder equity | -$38.03 | -$46.49 | -$36.94 | -$37.61 |
| Total shareholder equity | $1389.22 | $1444.57 | $1535.35 | $1551.81 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $95.88 | $153.19 | $134.71 | $72.21 |
| Short term investments | ||||
| Net receivables | $123.38 | $148.61 | $259.64 | $286.31 |
| Inventory | $65.7 | $74.06 | $86.5 | $132.34 |
| Total current assets | $309.48 | $394.52 | $823.01 | $523.18 |
| Long term investments | $16.08 | $28.08 | $10.73 | $15.73 |
| Property, plant & equipment | $143.52 | $121.6 | $123.95 | $178.29 |
| Goodwill & intangible assets | $1338.54 | $1419.37 | $842.28 | $1155.6 |
| Total noncurrent assets | $1702.22 | $1772.73 | $1576.7 | $1949.88 |
| Total investments | $16.08 | $28.08 | $10.73 | $15.73 |
| Total assets | $2011.7 | $2167.26 | $2399.72 | $2473.06 |
| Current liabilities | ||||
| Accounts payable | $69.68 | $66.99 | $82.04 | $100.88 |
| Deferred revenue | ||||
| Short long term debt | $40.29 | $48.22 | $26.32 | $33.73 |
| Total current liabilities | $200.05 | $213.48 | $330.01 | $375.48 |
| Long term debt | $268.46 | $226.56 | $221.03 | $251.75 |
| Total noncurrent liabilities | $422.43 | $392.13 | $384.58 | $426.03 |
| Total debt | $308.75 | $286.55 | $247.35 | $285.48 |
| Total liabilities | $622.48 | $605.61 | $714.59 | $801.51 |
| Shareholders' equity | ||||
| Retained earnings | -$2011.79 | -$1822.92 | -$1511.98 | -$1481.83 |
| Other shareholder equity | -$38.03 | -$43.32 | -$30.5 | -$4.22 |
| Total shareholder equity | $1389.22 | $1561.65 | $1685.13 | $1671.55 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $178.59 | $265.42 | $237.58 | |
| Cost of revenue | $130.92 | $138.94 | $138.31 | |
| Gross Profit | $47.68 | $126.48 | $99.26 | |
| Operating activities | ||||
| Research & development | $19.43 | $18.16 | $32.6 | |
| Selling, general & administrative | $72.24 | $79.79 | $75.64 | |
| Total operating expenses | $112.08 | $119.45 | $129.86 | |
| Operating income | -$64.41 | $7.03 | -$30.59 | |
| Income from continuing operations | ||||
| EBIT | -$75.01 | -$13.21 | -$13.64 | |
| Income tax expense | $6.08 | $3.15 | $1.23 | |
| Interest expense | $3.38 | $3.28 | $3.39 | |
| Net income | ||||
| Net income | -$84.47 | -$19.64 | -$18.27 | |
| Income (for common shares) | -$84.47 | -$19.64 | -$18.27 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $863.5 | $1004.2 | $1774.72 | $1435.41 |
| Cost of revenue | $545.37 | $715.98 | $1193.19 | $894.41 |
| Gross Profit | $318.13 | $288.22 | $581.52 | $541 |
| Operating activities | ||||
| Research & development | $89.59 | $73.89 | $76.85 | $75.32 |
| Selling, general & administrative | $300.56 | $372.67 | $468.86 | $355.57 |
| Total operating expenses | $475.15 | $514.47 | $562.77 | $483.29 |
| Operating income | -$157.02 | -$226.25 | $18.75 | $57.71 |
| Income from continuing operations | ||||
| EBIT | -$170.92 | -$379.85 | $4.23 | $70.14 |
| Income tax expense | $4.44 | -$63.5 | $15.49 | $17.62 |
| Interest expense | $13.51 | $12.06 | $18.88 | $21.93 |
| Net income | ||||
| Net income | -$188.86 | -$328.4 | -$30.14 | $30.59 |
| Income (for common shares) | -$188.86 | -$328.4 | -$30.14 | $30.59 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$66.48 | -$84.47 | -$19.64 | -$18.27 |
| Operating activities | ||||
| Depreciation | $25.98 | $26.32 | $26.55 | $26.45 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.67 | $3.22 | $2.81 | $2.72 |
| Total cash flows from operations | -$38.29 | $33.11 | -$0.36 | -$22.65 |
| Investing activities | ||||
| Capital expenditures | -$1.42 | -$3.94 | -$5.49 | -$2.72 |
| Investments | $0.36 | -$5 | ||
| Total cash flows from investing | -$1.42 | -$3.57 | -$5.49 | -$7.72 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $0.03 | -$0.3 | |
| Net borrowings | -$3.75 | $2.08 | $3.76 | -$13.12 |
| Total cash flows from financing | -$3.75 | $2.1 | $3.46 | -$13.12 |
| Effect of exchange rate | $0.72 | -$1.13 | -$0.33 | $1.12 |
| Change in cash and equivalents | -$42.74 | $30.51 | -$2.72 | -$42.36 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$188.86 | -$328.4 | -$30.14 | $30.59 |
| Operating activities | ||||
| Depreciation | $105.3 | $108.66 | $78.72 | $85.36 |
| Business acquisitions & disposals | -$1.76 | -$4 | ||
| Stock-based compensation | $11.41 | $18.51 | $13.63 | $8.95 |
| Total cash flows from operations | -$28.2 | -$95.19 | $38.34 | $39.48 |
| Investing activities | ||||
| Capital expenditures | -$13.56 | -$22.63 | $33.87 | -$33.44 |
| Investments | -$4.64 | $115.42 | $6.08 | $15.11 |
| Total cash flows from investing | -$18.2 | $91.04 | $35.95 | -$18.33 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.27 | -$0.77 | $1.08 | $0.76 |
| Net borrowings | -$11.03 | $23.75 | -$11.43 | -$35.83 |
| Total cash flows from financing | -$11.3 | $22.97 | -$10.35 | -$35.08 |
| Effect of exchange rate | $0.39 | -$0.34 | -$1.44 | $0.69 |
| Change in cash and equivalents | -$57.31 | $18.48 | $62.5 | -$13.24 |
News
Fundamentals
| Market cap | $989.51M |
|---|---|
| Enterprise value | $1.20B |
| Shares outstanding | 773.06M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.69 |
| Book/Share | 1.85 |
| Cash/Share | 0.12 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.45 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.55 |
| Quick ratio | 1.22 |